Aviv Regev

Aviv Regev is an Israeli–American computational and systems biologist known for pioneering work in single-cell genomics, cellular circuitry, and computational methods that link molecular profiling to cell function. She has held leadership positions at research institutes and biotechnology companies, contributing to large collaborative consortia and translational programs. Her work connects experimental platforms, algorithm development, and organizational initiatives spanning academic, corporate, and international projects.

Early life and education

Born in Haifa, Israel, she grew up amid scientific communities associated with the Technion and the Weizmann Institute, later attending the Hebrew University of Jerusalem and Tel Aviv University for undergraduate and masters-level training. She pursued doctoral studies at the University of California, Berkeley under mentors connected to computational biology groups with ties to the Howard Hughes Medical Institute and the Whitehead Institute, engaging with researchers from the Broad Institute, Massachusetts Institute of Technology, and Harvard Medical School. Her formative training intersected with networks including the European Molecular Biology Laboratory, the Max Planck Society, and collaborations involving the National Institutes of Health, shaping her interdisciplinary approach that bridged experimental platforms such as microarrays, next-generation sequencing, and early single-cell technologies.

Research career and contributions

She developed algorithms and conceptual frameworks for reconstructing cellular regulatory networks, integrating ideas from bioinformatics centers at the Broad Institute, the Salk Institute, Stanford University, and the University of California system. Her group introduced methods for single-cell RNA sequencing analysis used by consortia such as the Human Cell Atlas, the International Cancer Genome Consortium, and projects linked to the Wellcome Trust and the Chan Zuckerberg Initiative. Collaborations spanned laboratories associated with Cold Spring Harbor Laboratory, the Broad Institute, European bioinformatics hubs, and biotechnology companies including Genentech and Illumina, producing tools adopted by researchers at the Francis Crick Institute, EMBL-EBI, and the Pasteur Institute. Her publications influenced studies in immunology labs at the Dana-Farber Cancer Institute, cancer biology programs at Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, and developmental biology groups at Harvard Medical School and Stanford Medicine. Methodological advances from her team intersected with technologies developed by 10x Genomics, Pacific Biosciences, and Oxford Nanopore Technologies, and were applied in projects involving the National Human Genome Research Institute, the European Research Council, and the Simons Foundation. Her work informed translational efforts at pharmaceutical companies including Novartis, Pfizer, Roche, and Merck, and supported clinical research at Massachusetts General Hospital and Brigham and Women’s Hospital.

Industry leadership and roles

She has served in leadership roles linking academic and industrial ecosystems, including executive positions at Genentech, founding roles at biotechnology startups, and advisory posts for venture arms of Flagship Pioneering, Third Rock Ventures, and GV. Her leadership connected with nonprofit funders such as the Chan Zuckerberg Initiative and foundations like the Simons Foundation, and with government agencies including the National Science Foundation and the National Institutes of Health. She participated in initiatives alongside institutional partners like the Broad Institute, Massachusetts Institute of Technology, Harvard University, the Whitehead Institute, and the Wellcome Sanger Institute. Corporate collaborations involved strategic partnerships with Roche, Genentech, Illumina, 10x Genomics, and Regeneron, while advisory roles included boards and committees tied to the Human Cell Atlas, the Allen Institute for Brain Science, the American Association for the Advancement of Science, and international consortia funded by the European Commission.

Awards and honors

Her achievements have been recognized by awards and fellowships from organizations such as the Breakthrough Prize, the European Molecular Biology Organization, the Howard Hughes Medical Institute, the Paul G. Allen Frontiers Group, and the National Academy of Sciences. She has been honored by professional societies including the American Association for the Advancement of Science, the International Society for Computational Biology, the Royal Society of London (through collaborations), and the American Academy of Arts and Sciences. Additional recognitions include prizes and lectureships associated with Cold Spring Harbor Laboratory, the Kavli Foundation, the MacArthur Foundation, and distinguished appointments connected to the Broad Institute and Harvard Medical School.

Personal life and advocacy

She has been active in mentoring and advocacy efforts related to diversity and inclusion, partnering with organizations such as Women in Bio, the Society for Women in Science, and academic programs at MIT and Harvard that promote early-career scientists. Her advocacy intersected with global initiatives addressing reproducibility and open science championed by the European Research Council, the Wellcome Trust, and the Chan Zuckerberg Initiative, and with policy dialogues involving the National Institutes of Health, the National Academies, and international science ministries. Outside science, she has engaged with cultural institutions in Israel and the United States, including ties to the Weizmann Institute, the Technion, and arts organizations in Boston and San Francisco.

Category:Computational biologists Category:Systems biologists Category:Israeli scientists Category:American scientists